Welch & Forbes LLC decreased its holdings in  Waters Co. (NYSE:WAT – Get Rating) by 1.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,888 shares of the medical instruments supplier’s stock after selling 50 shares during the period. Welch & Forbes LLC’s holdings in Waters were worth $1,332,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Bank of Montreal Can boosted its position in  Waters by 63.5% during the 4th quarter. Bank of Montreal Can now owns 220,791 shares of the medical instruments supplier’s stock valued at $76,791,000 after buying an additional 85,746 shares during the period.  Trust Asset Management LLC purchased a new stake in  Waters during the 4th quarter valued at $232,000.  NorthRock Partners LLC boosted its position in  Waters by 19.7% during the 4th quarter. NorthRock Partners LLC now owns 918 shares of the medical instruments supplier’s stock valued at $314,000 after buying an additional 151 shares during the period.  Spartan Planning & Wealth Management purchased a new stake in  Waters during the 4th quarter valued at $322,000.  Finally, CWM LLC boosted its position in  Waters by 91.3% during the 4th quarter. CWM LLC now owns 331 shares of the medical instruments supplier’s stock valued at $113,000 after buying an additional 158 shares during the period. Hedge funds and other institutional investors own  88.58% of the company’s stock.

Several equities research analysts have weighed in on WAT shares. StockNews.com cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Sunday, April 9th. Robert W. Baird increased their price target on shares of Waters from $334.00 to $345.00 and gave the company a “neutral” rating in a research report on Thursday, February 16th. Wells Fargo & Company upped their price objective on shares of Waters from $320.00 to $345.00 and gave the stock an “equal weight” rating in a report on Thursday, February 16th. Barclays decreased their price objective on shares of Waters from $385.00 to $350.00 and set an “overweight” rating for the company in a report on Tuesday, April 4th. Finally, Citigroup upped their price objective on shares of Waters from $325.00 to $340.00 and gave the stock a “neutral” rating in a report on Thursday, February 16th. Nine investment analysts have rated the stock with a hold rating and one  has given a buy rating to the company. According to data from MarketBeat.com, the company  has a consensus rating of “Hold” and an average price target of $351.00.

Shares of Waters stock opened at $308.39 on Wednesday. The company has a debt-to-equity ratio of 3.02, a current ratio of 2.24 and a quick ratio of 1.66. The company has a 50-day moving average of $312.65 and a 200 day moving average of $319.24. The firm has a market cap of $18.20 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 3.60 and a beta of 0.86. Waters Co. has a 1 year low of $265.61 and a 1 year high of $369.00.

Waters (NYSE:WAT – Get Rating) last issued its quarterly earnings results on Wednesday, February 15th. The medical instruments supplier reported $3.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.74 by $0.10. The company had revenue of $858.51 million during the quarter, compared to analyst estimates of $832.85 million. Waters had a net margin of 23.81% and a return on equity of 175.08%. Waters’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the business earned $3.67 EPS.  As a group, sell-side analysts anticipate that  Waters Co. will post 12.67 earnings per share for the current fiscal year.

In other news, Director Mark P. Vergnano acquired 3,185 shares of Waters stock in a transaction on Tuesday, February 28th. The stock was acquired at an average cost of $313.32 per share, for a total transaction of $997,924.20. Following the purchase, the director now owns 3,557 shares in the company, valued at $1,114,479.24. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.77% of the stock is owned by company insiders.

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Get Rating).

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.